13588-95-9 Usage
Description
H-LEU-VAL-OH, also known as L-Leucine-L-Valine dipeptide, is a dipeptide composed of two amino acids, L-Leucine and L-Valine. It is a white powder with specific chemical properties that make it suitable for various applications in different industries.
Uses
Used in Pharmaceutical Industry:
H-LEU-VAL-OH is used as a therapeutic agent for inhibiting movement-induced muscle damage and muscle defective conditions. Its dipeptide structure allows for better absorption and utilization by the body, making it an effective treatment option for muscle-related issues.
Used in Sports Nutrition Industry:
H-LEU-VAL-OH is used as a performance enhancer and muscle recovery aid for athletes. Its ability to inhibit muscle damage and improve muscle function makes it a valuable addition to sports supplements and nutrition programs.
Used in Cosmetics Industry:
H-LEU-VAL-OH is used as an active ingredient in anti-aging and skin care products. Its dipeptide composition can help improve skin elasticity, reduce the appearance of fine lines and wrinkles, and promote overall skin health.
Used in Research and Development:
H-LEU-VAL-OH is used as a research compound for studying the effects of dipeptides on muscle function, protein synthesis, and other biological processes. Its unique properties make it an important tool in the development of new drugs and therapies for various conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 13588-95-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,5,8 and 8 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 13588-95:
(7*1)+(6*3)+(5*5)+(4*8)+(3*8)+(2*9)+(1*5)=129
129 % 10 = 9
So 13588-95-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H22N2O3/c1-6(2)5-8(12)10(14)13-9(7(3)4)11(15)16/h6-9H,5,12H2,1-4H3,(H,13,14)(H,15,16)/t8-,9-/m0/s1
13588-95-9Relevant articles and documents
DPP4 INHIBITOR AND PHARMACEUTICAL APPLICATION THEREOF
-
Page/Page column 8-9, (2008/06/13)
The present invention provides a Dpp4 inhibitor which comprises a leucine derivative of the following formula (1) or a methionine derivative of the following formula (2): wherein each R1 and R3 represents a hydrogen atom (H) and an L-amino acid residue; R2 represents a hydroxyl group (OH), alkoxy group having 1 to 6 carbon atoms, amino group (NH2), alkylamino group having 1 to 6 carbon atoms, glycine residue, β-alanine residue, L-amino acid (except for proline, alanine and phenylalanine) residue or L-amino-acid amide (except for proline amide, alanine amide and phenylalanine amide) residue; and R4 represents a hydroxyl group (OH), alkoxy group having 1 to 6 carbon atoms, amino group (NH2), alkylamino group having 1 to 6 carbon atoms, glycine residue, β-alanine residue, L-amino acid (except for proline and alanine) residue or L-amino-acid amide (except for proline amide and alanine amide) residue. These derivatives also act as autophagy regulators.
Urethane-protected amino acid-N-carboxyanhydrides
-
, (2008/06/13)
The invention relates to urethane-protected amino acid-N-carboxyanhydride and N-thiocarboxyanhydride compounds which are useful in peptide, polypeptide and protein synthesis. Disclosed herein is the preparation and use of these novel compounds.
